What medeConnect does

medeConnect is a UK-based healthcare market research consultancy that operates as the EU/UK research brand within M3 Global Group, delivering custom-designed primary research to global pharmaceutical and healthcare organisations. Founded in 2005 and registered in England and Wales as M3 (EU) Ltd., with its EU operations headquartered at One Valentine Place, London, the firm runs a small team (11–50 employees) and serves enterprise pharmaceutical clients across the full product lifecycle. Its offering is organised into four named services — Product Development, Product Launch, Product Growth, and GP Omnibus — delivered through three integrated capabilities: methodological expertise, healthcare fluency, and client-focused thinking.

The firm's core asset is its position within M3 Global Group's network of specialist healthcare professional platforms (m3.com, MDLinx, Doctors.net.uk, MEDI:GATE, Vidal Group, M3 India, iDoctus, and M3 Global Research), which collectively reach over six million healthcare professionals worldwide. On top of this network, medeConnect operates a recurring UK general practitioner panel — the GP Omnibus — a monthly online survey drawing on 1,000 regionally representative UK GPs. The client base is exclusively enterprise pharmaceutical companies, with work covering HCPs, payers, patients and carers, and system leaders and policy influencers.

medeConnect generates revenue through project-based professional services engagements sold via direct, consultative enterprise sales. Pricing is quote-based and tailored to individual project requirements, with no publicly disclosed fee structures, no recurring SaaS subscription, and no SMB or self-serve channel. The go-to-market relies on direct engagement with pharma brand teams, supported by a modest digital presence (LinkedIn, X/Twitter, eu.m3.com) and inbound contact via [email protected]. There is no disclosed funding history, consistent with its position as a wholly-owned subsidiary within M3 Global Group rather than a standalone, capital-raising entity.

Name

medeConnect

Legal name

M3 (EU) Ltd.

Website

https://medeconnect.net

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

medeConnect is a UK-based healthcare market research consultancy, operating as the EU research brand within M3 Global Group, that delivers custom primary research and a monthly UK GP Omnibus panel to global pharmaceutical clients across the product lifecycle.

Ownership category

akta.pro rank

Headquarters

HQ city

Abingdon

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Custom Healthcare Research Services: medeConnect provides strategic, custom-designed market research studies for pharmaceutical and healthcare organisations. Revenue is generated through project-based consulting engagements that support brand and product decisions across the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

medeConnect is a full-service healthcare market research consultancy delivering custom primary research to pharmaceutical and healthcare organisations across the product lifecycle. Its portfolio covers Product Development research (early pipeline validation), Product Launch research (evidence-backed launch planning), Product Growth research (ongoing strategic insight), and the GP Omnibus — a monthly online survey of 1,000 regionally representative UK GPs.

Product overview

medeConnect is a full-service healthcare market research consultancy offering a unified platform of research solutions organized across the product lifecycle. The portfolio comprises four core services: Product Development (early insights for pipeline strategy), Product Launch (evidence-backed launch preparation), Product Growth (ongoing strategic insights), and GP Omnibus (monthly UK GP panel). These services are delivered through three integrated core capabilities: Methodological Expertise (qualitative and quantitative study design), Healthcare Fluency (clinical and scientific understanding), and Client-Focused Thinking (business-aligned delivery).

Differentiator

Problem solved

Functional benefit

Products and services

• Product Development Research

Named customers3 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eight partnerships are on record, tiered core.

• m3.comcoreOthersPart of M3 Global Group's network of specialist healthcare platforms. m3.com provides access to Japanese healthcare professionals as part of the integrated M3 network that medeConnect operates within.
• MDLinxcoreOthersPart of M3 Global Group's network providing medical news and HCP engagement platforms. MDLinx serves US-based healthcare professionals as part of the integrated M3 network.
• Doctors.net.ukcoreOthersUK-specific HCP platform within M3 Global Group network. The largest professional network for UK doctors, providing UK market access for research and engagement.
• MEDI:GATEcoreOthersPart of M3 Global Group's network serving Korean healthcare professionals. Provides access to Korean HCP market for integrated research services.
• Vidal GroupcoreOthersM3 Global Group subsidiary providing drug and medical information databases, primarily serving French healthcare professionals with pharmaceutical reference data.
• M3 IndiacoreOthersM3 Global Group's Indian platform providing access to healthcare professionals in India's growing pharmaceutical market.
• iDoctuscoreOthersM3 Global Group's Spanish and Latin American HCP platform providing medical content and engagement services to Spanish-speaking healthcare professionals.
• M3 Global ResearchcoreOthersThe market research division of M3 Global Group that encompasses medeConnect. Provides integrated global healthcare market research services across all M3 platforms.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• IQVIA: IQVIA is the largest global healthcare market research and analytics provider, offering primary research, real-world evidence, and commercial consulting to pharma clients. It is the dominant broad incumbent against which all niche healthcare MR firms, including medeConnect, compete on enterprise accounts.
• Kantar Health (now part of Lumanity / Kantar):

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medeConnect
• LinkedInlinkedin.com/company/medeconnect

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about medeConnect